Treatment

2:29
MDS: future directions
Galia Bartfeld-Stemer
3:00
MDS: what treatments are on the horizon?
Rafael Bejar
10:19
An in-depth look at MDS
Galia Bartfeld-Stemer
2:09
Brian Koffman on CLL: personal to professional
Brian Koffman
0:48
The need for increased care and support for patients with high-risk multiple myeloma
Cynthia Chmielewski
1:49
Encouraging patients to ask about clinical trials
Simon Rule
5:44
What is the best therapy for a young patient with relapsed/refractory CLL?
Jacqueline Barrientos
1:06
Promising treatments are coming: a message to lymphoma and CLL patients
George Follows
2:04
A message for CLL patients in French from ASH 2017
Florence Cymbalista
2:36
From the MD Anderson Cancer Center: Chronic lymphocytic leukemia (CLL) patient’s journey to a stem cell transplant
Harley Hudson
8:44
From CML Advocates: Treatment-free remission in chronic myeloid leukaem
Giora Sharf et al.
1:41
What is the purpose of whole genome sequencing?
Wim van Harten
4:08
Autologous stem cell transplant in Lymphoma patients
Anna Sureda
1:35
Bladder-sparing treatments: an alternative to bladder removal for bladder cancer patients
Anne Kiltie
1:07
Genetic mutations may alter treatment courses for patients with MPNs
Alessandro Vannucchi
2:10
MPN treatment: traditional, new and upcoming drug insights
Tiziano Barbui
The content of VJHemOnc is intended for healthcare professionals